record #395881755098806 | blhc | 67995026 | | 8981830 | 5/19/2006 12:00:00 am | s/p rt tkr | | dis | admission date: 0/21/2006 report status:discharge date: 2/22/2006 final discharge orders lieberman , theron jewell 014-92-16-4donpool ave. , west tul jo , florida 39640service: ortdischarge patient on: 5/7/06 at 01:00 pmcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: puckhaber , truman , m.d.disposition: rehabilitationdischarge medications:tylenol ( acetaminophen ) 650 mg po q4hstarting today ( 1/7 )prn pain , headache , other:fever greater thaninstructions: do not exceed 4000mg in 24 hours.calcium carbonate ( 500 mg elemental ca++ )500 mg po dailycolace ( docusate sodium ) 100 mg po bidfamotidine 20 mg po bidinsulin regular humansliding scale ( subcutaneously ) sc q6hif bs is less than 125 , then give 0 units subcutaneouslyif bs is 125-150 , then give 2 units subcutaneouslyif bs is 151-200 , then give 3 units subcutaneouslyif bs is 201-250 , then give 4 units subcutaneouslyif bs is 251-300 , then give 6 units subcutaneouslyif bs is 301-350 , then give 8 units subcutaneouslyif bs is 351-400 , then give 10 units subcutaneously andcall ho call ho if bs is greater than 400levothyroxine sodium 50 mcg po dailyalert overridden: override added on 2/22/06 bysimkulet , sonny , m.d.serious interaction: warfarin &amp; levothyroxine sodiumreason for override: will monitormvi ( multivitamins ) 1 tab po dailyoverride notice: override added on 2/22/06 byblacock , devin , m.d.on order for zocor po ( ref # 282011332 )potentially serious interaction: niacin , vit. b-3 &amp;simvastatin reason for override: will monitoroxycodone 5 mg po q6h starting today ( 1/7 ) prn painhold if: somnolent , mental status changescoumadin ( warfarin sodium ) 6 mg po x1instructions: dose for 9/10/06. monitor a daily pt/inr inrehab and adjust the dose for a goal inr of1.5-2.5;dvt prophylaxis is planned x 3 weeksfood/drug interaction instructionno high vitamin-k containing foodsoverride notice: override added on 2/22/06 byvergin , merlin , m.d.on order for zocor po ( ref # 282011332 )potentially serious interaction: warfarin &amp; simvastatinreason for override: will monitorprevious override information:override added on 2/22/06 by gumz , kennith , m.d.on order for levothyroxine sodium po ( ref # 031373863 )serious interaction: warfarin &amp; levothyroxine sodiumreason for override: will monitornorvasc ( amlodipine ) 10 mg po dailystarting in am ( 3/5 ) hold if: sbp &lt; 110food/drug interaction instructionavoid grapefruit unless md instructs otherwise.metformin 500 mg po bidstarting when tolerating ada dietoxycontin ( oxycodone controlled release ) 10 mg po q12hhyzaar ( 25 mg/100 mg ) ( hydrochlorthiazide 25m... )1 tab po daily starting in am ( 3/5 ) hold if: sbp &lt; 110number of doses required ( approximate ): 6actos ( pioglitazone ) 15 mg po dailystarting when tolerating ada dietfood/drug interaction instructionmay be taken without regard to mealsinsulin nph human 42 units sc qam hold if: npoferrous sulfate 325 mg po tidfood/drug interaction instruction avoid milk and antaciddiet: house / low chol/low sat. fatactivity: weight bear as tolerated with ue supportfollow up appointment( s ):dr emore 1/30/06 xray at 2:00pm appt at 3:00pm 8/1/06 ,arrange inr to be drawn on 2/5/06 with f/u inr's to be drawn everymonday/thursday days. inr's will be followed by cmh anticoagulation service , 854.354.8117allergy: lisinopriladmit diagnosis:oa rt kneeprincipal discharge diagnosis ;responsible after study for causing admission )s/p rt tkrother diagnosis;conditions , infections , complications , affecting treatment/stayosteoarthritis , hypertension , diabuetes mellitus , hypothyroidismoperations and procedures:2/22/06 climes , sam , m.d.rt tkrother treatments/procedures ( not in o.r. )n/abrief resume of hospital course:pt underwent a rt tkr on 4/3/06 for endstage oa. the patient toleratedthe procedure well , and had an uncomplicated post-operative course on thetkr pathway with exception of post-op delerium which required a sitterfor safety on pod 2. patients ms gradually improved , and returned tobaseline by pod 3 , at which time the sitter was discontinued. pt was hdstable with no transfusion requirements during her hospitalization. hctwas trending up on pod 4 at 28.7. standard care with pcea for acute painmanagement/cpm , prophylactic iv abx , and coumadin/teds/p-boots for dvtprophylaxis. pt mobilized oob with pt wbat. refer to the page 3 forrom/functional details. wound clean and healing at time of discharge. ptstable for transfer to rehab on pod 4.additional comments: dsd qd. the wound may be left ota when dry. staples may be removed inrehab or by the vna as of 5/22/06 , please sterristrip the wound. continueteds for dvt prophylaxis. when the patient is discharged home , pleasearrange blood draws for pt/inr q mon/thurs with results called to the ahcanticoagulation service uv019-996-6307 exp 6 for outpatientanticoagulation management. goal inr is 1.5-2.5;dvt prophyalxis is plannedx 3 weeks. any outpatient anticoagulation issues or action values shouldbe called to the anticoagulation service.discharge condition: stableto do/plan:arrange blood draws for pt/inr q mon/thurs with results called to777-899-3368 wxr 6 for outpatient anticoagulation managementnotify the anticoagulation service when the patient is discharged homestaple removal 5/26/06follow up with dr jantz as scheduledno dictated summaryentered by: earenfight , leopoldo , pa-c ( jw37 ) 5/7/06 @ 12 end of discharge orders [report_end]